Article Sidebar

pdf
Date Published: 19/09/2025
Abstract Views: 54
Views pdf: 31
DOI: https://doi.org/10.51298/vmj.v553i3.15466
Issue
Vol. 553 No. 3 (2025)
Section
Các bài báo
How to Cite
Nguyễn, T. K. O., Nguyễn, H. H., & Nguyễn, V. H. (2025). POST-DISCHARGE MEDICATION ADHERENCE AMONG INPATIENTS WITH TUBO-OVARIAN ABSCESS AT TU DU HOSPITAL. Vietnam Medical Journal, 553(3). https://doi.org/10.51298/vmj.v553i3.15466

POST-DISCHARGE MEDICATION ADHERENCE AMONG INPATIENTS WITH TUBO-OVARIAN ABSCESS AT TU DU HOSPITAL

Thị Kim Oanh Nguyễn, Hồng Hoa Nguyễn, Văn Hưng Nguyễn

Main Article Content

Abstract

Objective: To determine the rate of post-discharge medication adherence and factors associated with non-adherence among hospitalized TOA patients at Tu Du Hospital. Methods: A prospective cohort study was conducted on 129 inpatients diagnosed with TOA at Tu Du Hospital from December 2024 to May 2025. Treatment adherence was assessed using the MMAS-8 scale after the patients completed their outpatient antibiotic regimen. Results: The overall post-discharge adherence rate was 81.4%, including 50.4% with high adherence, 31.0% moderate, and 18.6% non-adherent. Two factors independently associated with non-adherence were age ≤ 24 years (adjusted OR = 6.1; p = 0.01) and hospitalization duration ≤ 5 days (adjusted OR = 6.0; p = 0.01). Conclusion: While post-discharge adherence among TOA inpatients was relatively good, nearly one-fifth of patients failed to complete their antibiotic regimen. Younger patients and those discharged early were at higher risk of non-adherence

Article Details

Keywords

tubo-ovarian abscess, medication adherence, post-discharge, MMAS-8, antibiotics.

References

1. Granberg S, Gjelland K, Ekerhovd E. The management of pelvic abscess. Best Pract Res Clin Obstet Gynaecol. 2009;23(5):667–78.
2. World Health Organization. Guidelines for the management of symptomatic sexually transmitted infections. Geneva: World Health Organization; 2021.
3. He D, Wang T, Ren W. Global burden of pelvic inflammatory disease and ectopic pregnancy from 1990 to 2019. BMC Public Health. 2023; 23(1):1894.
4. Das BB, Ronda J, Trent M. Pelvic inflammatory disease: improving awareness, prevention, and treatment. Infect Drug Resist. 2016:191–7.
5. Religioni U, Barrios-Rodríguez R, Requena P, Borowska M, Ostrowski J. Enhancing therapy adherence: impact on clinical outcomes, healthcare costs, and patient quality of life. Medicina (Kaunas). 2025;61(1):153.
6. Sabaté E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
7. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 218: Chronic pelvic pain. Obstet Gynecol. 2020;135(3):e98–e109.